Celeste M Boesjes

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 8

Top Topics

Replacement Therapy

Neuropathic Pain

Atopic Dermatitis

Top Venues

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Celeste M Boesjes, Madelon van Emst, Daphne S Bakker, Lotte S Spekhorst, Femke van Wijk, Marlies de Graaf, Marjolein S de Bruin-Weller
Muscle and joint pain during dupilumab treatment for atopic dermatitis: Lack of association with antinuclear antibodies. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2023)
Celeste M Boesjes, Daphne S Bakker, Edward F Knol, Marlies de Graaf, Femke van Wijk, Marjolein S de Bruin-Weller
Differential dynamics of TARC during JAK-inhibitor therapy compared to biological therapies targeting type 2 inflammation. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 54 (4) (2023)
Celeste M Boesjes, Daphne S Bakker, Edward F Knol, Marlies de Graaf, Femke van Wijk, Marjolein S de Bruin-Weller
Differential dynamics of TARC during JAK-inhibitor therapy compared to biological therapies targeting type 2 inflammation. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2023)
Celeste M Boesjes, Daphne S Bakker, Edward F Knol, Marlies de Graaf, Femke van Wijk, Marjolein S de Bruin-Weller
Differential dynamics of TARC during JAK-inhibitor therapy compared to biological therapies targeting type 2 inflammation. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 54 (4) (2023)
Celeste M Boesjes, Daphne S Bakker, Edward F Knol, Marlies de Graaf, Femke van Wijk, Marjolein S de Bruin-Weller
Differential dynamics of TARC during JAK-inhibitor therapy compared to biological therapies targeting type 2 inflammation. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2023)
Roselie E Achten, Daphne S Bakker, Chantal M van Luijk, M Marlot van der Wal, Marlies de Graaf, Femke van Wijk, Nicolaas P A Zuithoff, Lisa P van der Rijst, Celeste M Boesjes, Judith L Thijs, Joke H de Boer, Marjolein de Bruin-Weller
Ocular surface disease is common in moderate-to-severe atopic dermatitis patients. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 52 (6) (2022)
Esmé Kamphuis, Celeste M Boesjes, Laura Loman, Daphne S Bakker, Mila Poelhekken, Nicolaas P A Zuithoff, Marijke Kamsteeg, Geertruida L E Romeijn, Femke Van Wijk, Marjolein de Bruin-Weller, Marlies de Graaf, Marie-Louise A Schuttelaar
Dupilumab in daily practice for the treatment of pediatric atopic dermatitis: 28-week clinical and biomarker results from the BioDay registry. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 33 (12) (2022)
Esmé Kamphuis, Celeste M Boesjes, Laura Loman, Daphne S Bakker, Mila Poelhekken, Nicolaas P A Zuithoff, Marijke Kamsteeg, Geertruida L E Romeijn, Femke Van Wijk, Marjolein de Bruin-Weller, Marlies de Graaf, Marie-Louise A Schuttelaar
Dupilumab in daily practice for the treatment of pediatric atopic dermatitis: 28-week clinical and biomarker results from the BioDay registry. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 33 (12) (2022)